Medicare Enrolled

Dr. Allison Holm, M.D.

Procedural Dermatology Physician · Rochester, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
30 N UNION ST, Rochester, NY 14607
5852328940
Registered in NPPES since 2005
NPI: 1114928231 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Holm from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Holm? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Holm

Dr. Allison Holm is a procedural dermatology physician in Rochester, NY, with 21 years of NPI registration. Based on federal Medicare data, Dr. Holm performed 1,298 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Holm received a total of $3,630 from 30 pharmaceutical and/or device companies across 151 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Holm is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years of NPI registration ▲ 1,298 Medicare services $3,630 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
1,298
Medicare services
Bottom 36% in NY for procedural dermatology physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$35
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
571 $5 $13
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
355 $58 $175
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
197 $42 $131
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
62 $68 $197
Destruction of 15 or more precancerous skin growths
This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer.
32 $118 $329
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
24 $67 $217
Additional skin growth biopsy
Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session.
22 $38 $98
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
20 $74 $220
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
15 $98 $249
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,630
Total received (2018-2024)
Avg $519/year across 7 years
Top 46% in NY for procedural dermatology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
151
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$412
2023
$412
2022
$372
2021
$334
2020
$388
2019
$943
2018
$768

Payments by company (2024)

Janssen Biotech, Inc.
$151
ABBVIE INC.
$114
Galderma Laboratories, L.P.
$37
Amgen Inc.
$28
UCB, Inc.
$23
Verrica Pharmaceuticals Inc.
$23
SUN PHARMACEUTICAL INDUSTRIES INC.
$20
Dermavant Sciences, Inc.
$17
Top 3 companies account for 73.1% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$828
Lilly USA, LLC
$321
AbbVie Inc.
$246
ABBVIE INC.
$203
Ortho Dermatologics, a division of Bausch Health US, LLC
$182
Novartis Pharmaceuticals Corporation
$178
AbbVie, Inc.
$159
Regeneron Healthcare Solutions, Inc.
$149
DERMIRA, INC.
$122
PFIZER INC.
$118
Galderma Laboratories, L.P.
$116
Janssen Scientific Affairs, LLC
$112
LEO Pharma Inc.
$98
Celgene Corporation
$94
Sun Pharmaceutical Industries Inc.
$92
GENZYME CORPORATION
$81
Incyte Corporation
$81
UCB, Inc.
$72
Amgen Inc.
$49
VYNE Pharmaceuticals Inc.
$47
E.R. Squibb & Sons, L.L.C.
$45
Boehringer Ingelheim Pharmaceuticals, Inc.
$44
Allergan Inc.
$36
PruGen, Inc. Pharmaceuticals
$35
Dermavant Sciences, Inc.
$30
Verrica Pharmaceuticals Inc.
$23
SUN PHARMACEUTICAL INDUSTRIES INC.
$20
Bayer HealthCare Pharmaceuticals Inc.
$19
Biofrontera Inc.
$16
Taro Pharmaceuticals USA, Inc.
$13
Top 3 companies account for 38.4% of all-time payments
Associated products mentioned in payments ›
AKLIEF · AMZEEQ · Absorica LD · Ameluz · BOTOX COSMETIC · BRYHALI · Bimzelx · COSENTYX · CYLTEZO · Cimzia · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIDEL · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Finacea · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · LIBTAYO · OPZELURA · ORACEA · Otezla · QBREXZA · REMICADE · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · SPEVIGO · Skyrizi · Sotyktu · TALTZ · TREMFYA · Tremfya · ULTRAVATE (halobetasol propionate) lotion · VTAMA · Winlevi · YCANTH
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a procedural dermatology physician in Rochester?
Compare procedural dermatology physicians in the Rochester area by procedure volume, costs, and industry payment transparency.
Browse procedural dermatology physicians nearby

Geographic Context

Procedural dermatology physicians in nearby ZIP areas
5
County median income
$74,409
Nearest hospital to ZIP centroid (approximate)
ROCHESTER PSYCHIATRIC CENTER
1.8 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Holm is a clinical cardiology specialist, with moderate Medicare volume, with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Holm experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Holm performed 571 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Holm receive payments from pharmaceutical companies?
Yes. Dr. Holm received a total of $3,630 from 30 companies across 151 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Holm's costs compare to other procedural dermatology physicians in Rochester?
Dr. Holm's average Medicare payment per service is $35. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Holm) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →